2nd Annual Pediatric Surgical Innovation Symposium
Lessons from Drugs to Devices: A Pediatric Perspective
October 24, 2013 | The Knight Conference Center at The Newseum, Washington, DC
Program
7:30A
Registration & Breakfast
8:00A
Welcome & Introduction
Kurt Newman, MD | President & CEO, Children’s National Health SystemPeter Kim, MD, PhD | Vice President, Sheikh Zayed Institute for Pediatric Surgical Innovation
8:15A
Opening: Lessons from Drugs to Devices
MODERATORSamuel Maldonado, MD | Vice President of CHILD, Janssen Pharmaceuticals company of Johnson & Johnson
PANEL
Mark Batshaw, MD | Chief Academic Officer & Physician-in-Chief, Children's National Health System
Michael Klein, MD | President, The American Pediatric Surgical Association
Matthew Laughon, MD, MPH | Faculty, Duke Clinical Research Institute Hari Sachs, MD | FDA
Jeffrey F. Smith, PhD | Partner, McKinsey & Company
9:15A
Clinical & Regulatory Pathways for Pediatric Devices
MODERATORTim Moran, MBA | Founder & CEO, PediaVascular
PANEL
Tara Federici | Vice President, AdvaMed
Simon Goodall | Goodall Consulting, LLC
Greg Mathison | Regulatory Strategies, Inc
Scott Mindrebo | Director of Regulatory Affairs, Cyberonics, Inc.
Jeanmarie Sales | Distinguished Regulatory Advisor, Medtronic
10:15A
Break & Networking
10:30A
Make Your Medical Device Pitch For Kids!
MODERATOR Mark Fitzgerald, JD | Partner, The Law Firm of Wilson Sonsini Goodrich & Rosatti JUDGES Charles Berul, MD | Chief of Cardiology, Children’s National Health System Michael Harrison, MD | founding director of UCSF's Fetal Treatment Center, UCSF Evan Jones, MBA | Managing Member, jVen Capital, LLC Peyvand Khaleghian, MD | Managing Partner, Avicenna Partners Investment Company LLC, Dubai Tim Moran, MBA | Founder & CEO, PediaVascular12:00P
Lunch
1:00P
Frontline of Pediatric Device Innovation
MODERATORJames Geiger, MD | Executive Director, Michigan Pediatric Device Consortium
PANEL
Robert Campbell, MD | Pediatric Surgeon, CHOP (Children's Hospital of Philadelphia)
Jim Gilkerson, DVM | Distinguished Corporate Fellow & Medical Advisor, Boston Scientific
Bruce Gingles | Vice President, Global Technology Assessment & Health Policy, Cook Medical
James Love, JD | Partner, Oblon Spivak
Amy Schwartz, PhD | Founder, IDEO's Chicago's User Research Group
Linda Ulrich, MD | Office of Orphan Products Development, FDA
2:00P
Growth Capital for Pediatric Innovation: The Good, The Bad, and The Ugly
MODERATORMargaret Kavalaris, JD | Partner and US General Counsel, Dentons PANEL William Bentley, PhD | Chair, Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland Mark Chandler, MBA | Managing Director, Upstream Partners Steven Hirschfeld, MD | Associate Director, Clinical Trials, NICHD Loudon McLean Owen, MBA | Managing Partner, McLean Watson Venture Capital Luke Pederson, JD | Partner, Baker Botts Semih Sen | Senior Advisor, Mubadala Healthcare, Abu Dhabi
3:00P
Break & Networking
3:15P
Coverage & Reimbursement: What We Learn From Payors
MODERATORKara Haas, MD, MPH | Director, Strategic Regulatory Affairs, Johnson & Johnson
PANEL William Fried, MD | Vice President, Aetna
Richard Migliori, MD | Executive Vice President, United Health Group
Lakshman Ramamurthy, PhD | Director, Avalere Health
Anthony Sandler, MD | Senior Vice President, Joseph E. Robert, Jr., Center for Surgical Care at Children's National Health System
Murray Sheldon, MD | Associate Director for Technology and Innovation, FDA
4:15P
Keynote: Accelerating Research Development for Rare Diseases & Orphan Products
KEYNOTE SPEAKERMargaret Hamburg, MD | Commissioner, US Food and Drug Administration